For the Kritzberger family, farming the soil of the Red River Valley has always been a balancing act between hard labor and tight margins. But for the last decade, their biggest struggle hasn’t been crop yields or debt; it has been managing their daughter Nina’s Type 1 diabetes. Despite having insurance, the family found themselves shelling out upwards of 8,000 dollars annually for medications and supplies, facing a healthcare system where life saving medication often comes with a staggering price tag.
This financial strain is a story shared by millions across the country, leading to a rare moment of political alignment in North Dakota. While Republicans typically favor free market solutions and Democrats lean toward government intervention, both sides agreed that the insulin market had simply stopped working for the people who needed it most. This consensus paved the way for legislation that caps patient insulin costs at 25 dollars a month, making North Dakota one of nearly thirty states to take similar action against skyrocketing drug prices.
The road to passing the cap was not without friction. Insurance lobbyists and business groups warned that capping costs for some would inevitably drive up premiums for others, arguing against government mandates in healthcare. For Democratic Senator Tim Mathern, one of only five Democrats in his senate chamber, finding common ground among forty two Republicans required persistence and powerful testimony from families like the Kritzbergers, who traveled hours to Bismarck to share their struggles at the capitol.
Now seventeen, Nina lives with the constant mental load of monitoring pumps and sensors to avoid life threatening complications. For her and her parents, the law represents more than just monthly savings; it provides a critical safety net against future price spikes. By removing the fear that a high deductible could suddenly make her medication unaffordable, the state has provided these families with something far more valuable than money: peace of mind.
